These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9988612)
1. Renal atrophy associated with long-term treatment with indinavir. Hanabusa H; Tagami H; Hataya H N Engl J Med; 1999 Feb; 340(5):392-3. PubMed ID: 9988612 [No Abstract] [Full Text] [Related]
2. Severe hypertension and renal atrophy associated with indinavir. Cattelan AM; Trevenzoli M; Naso A; Meneghetti F; Cadrobbi P Clin Infect Dis; 2000 Mar; 30(3):619-21. PubMed ID: 10722466 [No Abstract] [Full Text] [Related]
3. A side effect of protease inhibitors. Teitel J CMAJ; 1998 May; 158(9):1129-30. PubMed ID: 9597957 [No Abstract] [Full Text] [Related]
4. Platelet dysfunction as the cause of spontaneous bleeding in two haemophilic patients taking HIV protease inhibitors. Pollmann H; Richter H; Jürgens H Thromb Haemost; 1998 Jun; 79(6):1213-4. PubMed ID: 9657450 [No Abstract] [Full Text] [Related]
5. Indinavir sulfate renal toxicity in a pediatric hemophiliac with HIV infection. Ascher DP; Lucy MD Ann Pharmacother; 1997 Oct; 31(10):1146-9. PubMed ID: 9337438 [TBL] [Abstract][Full Text] [Related]
6. Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients. Brodie SB; Keller MJ; Ewenstein BM; Sax PE AIDS; 1998 Dec; 12(18):2433-7. PubMed ID: 9875581 [TBL] [Abstract][Full Text] [Related]
7. Indinavir-associated asymptomatic nephrolithiasis and renal cortex atrophy in two HIV-1 infected children. van Rossum AM; Dieleman JP; Fraaij PL; Cransberg K; Hartwig NG; Gyssens IC; de Groot R AIDS; 2001 Sep; 15(13):1745-7. PubMed ID: 11546957 [No Abstract] [Full Text] [Related]
9. [Reversibility of severe hyperlipemia secondary to indinavir with micronized phenofibrate]. de Luis DA; Aller R; Rachiller P; Ignacio Tortosa J Med Clin (Barc); 1999 Nov; 113(18):716-7. PubMed ID: 10650577 [No Abstract] [Full Text] [Related]
11. The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity. Boyd MA; Siangphoe U; Ruxrungtham K; Reiss P; Mahanontharit A; Lange JM; Phanuphak P; Cooper DA; Burger DM J Antimicrob Chemother; 2006 Jun; 57(6):1161-7. PubMed ID: 16595641 [TBL] [Abstract][Full Text] [Related]
12. Subtle occurrence of indinavir-induced acute renal insufficiency. Viganò A; Rombolà G; Barbiano di Belgioioso G; Sala N; Principi N AIDS; 1998 May; 12(8):954-5. PubMed ID: 9631152 [No Abstract] [Full Text] [Related]
13. Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor. Carr A; Brown D; Cooper DA AIDS; 1997 Nov; 11(13):1657-8. PubMed ID: 9365776 [No Abstract] [Full Text] [Related]
14. High prevalence of indinavir-associated renal complications in Thai HIV-infected patients. Avihingsanon A; Avihingsanon Y; Darnpornprasert P; Kerr S; Ungsedhapand C; Duncombe C; Ubolyam S; Ruxrungtham K; Phanuphak P J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S21-7. PubMed ID: 17044450 [TBL] [Abstract][Full Text] [Related]